Hedge Funds Aren't Crazy About Amarin Corporation plc (ADR) (AMRN) Anymore
In the financial world, there are many metrics shareholders can use to track their holdings. A duo of the most innovative are hedge fund and insider trading movement.
Orexigen Therapeutics Inc (OREX)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA), Orexigen Therapeutics, Inc. (OREX): Who Will Be the Winner in the Fight Against Obesity?
The obesity segment of the health care industry is turning into a battleground. VIVUS, Inc.
MannKind Corporation (MNKD), Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS) - Attention Biotech Investors: Stop Looking at Share Price
The reader is arguing, as you can see from the chart, that MannKind Corporation (NASDAQ:MNKD) hasn't reached the level it was the last time it was on the cusp of an approval for its inhaled insulin Afrezza...
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Can the Newly Discovered Obesity Genes Help You Lose Weight?
Quite a few research papers published recently have shown that mutations in genes can control your appetite and your ability to burn calories.
Arena Pharmaceuticals, Inc. (ARNA): Nothing to See Here, No Huge Sales Yet
What investors should be paying attention to is management's comments on the plans to accelerate sales from here.
Will Arena Pharmaceuticals, Inc. (ARNA) Earnings Finally Explode Higher?
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) will release its quarterly report on Thursday, and it looks like the company might finally get itself into the black for the quarter.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): How You Should Play These Weight-Loss Drug Companies
The two weight-loss drug approvals in 2012 were the first in more than a decade. The excitement surrounding Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’ Belviq and VIVUS, Inc.
VIVUS, Inc. (VVUS), AstraZeneca plc (ADR) (AZN): Great Job, Now You're Fired
"As a founding CEO, over the past 22 years, Leland has secured four drug approvals, an unheard-of achievement for a small pharmaceutical company. He has taken VIVUS, Inc.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): One Weight-Loss Drug That Investors Forgot
You know Belviq and Qsymia and Contrave and Empatic, but do you recall the still most widely used weight-loss drug of all? It seems almost like ancient history now, but back in 1999 the Food and Drug ...
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
